Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-08046031 in adults with advanced melanoma and other solid tumors
NL-OMON60914Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jun 2025
- Countries
- 1
01
Overview
Phase 1, single-arm trial of PF-08046031 in melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC) and 1 more, sponsored by Pfizer. Primary endpoint: Primary endpoint(s). Started Jun 2025; status: completed.
02
Drugs
PF-08046031
03
Conditions
melanomanon-small cell lung cancer (NSCLC)head and neck squamous cell carcinoma (HNSCC)esophageal cancer
Beyond the preview
Go deeper on NL-OMON60914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60914.